Mevalonate kinase deficiency impairs several aspects of the patient's quality of life, thus early diagnosis and treatment are required to improve health-related quality of life (HRQOL). The gene discussed is MVK; the disease is hyperinsulinemic hypoglycemia, familial, 4.